NASDAQ · Financial Statements

Nutex Health Inc. (NUTX) Revenue, Earnings & Financial Statements

$174.51 NASDAQ: NUTX Market Cap $1.20B

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

Nutex Health Inc. most recently reported annual revenue of $875.0M, net profit of $71.0M. Revenue grew at an average annual rate of 26.1% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Nutex Health Inc.: net profit was positive in 6 of 10 reported years; operating margin moved from -10165.0% to 31.5%, a shift of +10196.5 percentage points; the most recent year shows net profit of $71.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$0$0$1.0M$97.0M$274.0M$332.0M$219.0M$248.0M$480.0M$875.0M
Operating Expenses$0$2.0M$2.0M$62.0M$121.0M$161.0M$626.0M$279.0M$349.0M$600.0M
Operating Profit$0−$2.0M−$1.0M$35.0M$153.0M$170.0M−$407.0M−$32.0M$131.0M$276.0M
Operating Margin—-10165.0%-61.5%35.8%55.9%51.4%-185.4%-12.8%27.2%31.5%
Other Income$0−$4.0M$0−$3.0M−$7.0M−$1.0M−$13.0M−$17.0M−$21.0M−$31.0M
Interest$0$0$0$4.0M$6.0M$6.0M$12.0M$16.0M$20.0M$22.0M
Depreciation$0$1.0M$0$2.0M$6.0M$8.0M$13.0M$18.0M$19.0M$21.0M
Profit Before Tax$0−$6.0M−$1.0M$32.0M$146.0M$169.0M−$420.0M−$48.0M$110.0M$245.0M
Tax rate (%)0.0%0.0%0.0%0.0%0.1%0.6%-3.1%10.4%13.2%26.3%
Net Profit−$7.0M$1.0M−$3.0M$21.0M$106.0M$133.0M−$425.0M−$46.0M$52.0M$71.0M
EPS−$3.60−$0.07−$0.02$4.88$24.69$33.55−$100.36−$10.39$9.71$10.48

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$70.0M$67.0M$76.0M$79.0M$258.0M$212.0M$244.0M$268.0M$152.0M$216.0M$211.0M$218.0M
Operating Expenses$96.0M$66.0M$71.0M$69.0M$143.0M$140.0M$210.0M$137.0M$121.0M$135.0M$89.0M$141.0M
Operating Profit−$26.0M$1.0M$5.0M$10.0M$114.0M$72.0M$34.0M$130.0M$31.0M$81.0M$122.0M$77.0M
Operating Margin-37.5%2.1%7.0%12.3%44.3%34.1%13.8%48.7%20.4%37.5%57.8%35.4%
Interest$4.0M$4.0M$5.0M$5.0M$5.0M$6.0M$6.0M$5.0M$5.0M$5.0M$5.0M$5.0M
Profit Before Tax−$31.0M$0$4.0M−$3.0M$109.0M$63.0M$24.0M$124.0M$26.0M$77.0M$117.0M$73.0M
Tax rate (%)9.8%-255.0%22.9%-177.7%7.9%29.5%32.0%21.9%35.9%18.0%17.7%20.9%
Net Profit−$32.0M$0$0−$9.0M$62.0M$15.0M−$18.0M$55.0M$12.0M$47.0M$66.0M$40.0M
EPS−$7.50−$0.08−$0.07−$1.72$11.58$2.56−$3.02$7.76$1.62$6.52$9.38$5.71

Over the 10 years reported for Nutex Health Inc., cash stood at $186.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 3.41 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$1.0M$3.0M$0$179.0M$309.0M$395.0M$432.0M$398.0M$655.0M$919.0M
Current Assets$1.0M$0$0$46.0M$136.0M$154.0M$98.0M$91.0M$292.0M$539.0M
Cash$0$0$0$8.0M$26.0M$36.0M$34.0M$22.0M$44.0M$186.0M
Inventory$0$0$0$1.0M$2.0M$3.0M$4.0M$3.0M$3.0M$3.0M
Receivables$0$0$0$36.0M$108.0M$115.0M$58.0M$63.0M$236.0M$325.0M
Fixed Assets$0$0$0$131.0M$171.0M$238.0M$295.0M$269.0M$325.0M$344.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$0$0$0$0$0$0$0$0
Other Assets$0$0$0$3.0M$1.0M$1.0M$17.0M$17.0M$14.0M$14.0M
Total Liabilities$6.0M$1.0M$2.0M$128.0M$161.0M$203.0M$311.0M$319.0M$453.0M$495.0M
Current Liabilities$6.0M$1.0M$1.0M$72.0M$31.0M$38.0M$55.0M$58.0M$141.0M$158.0M
Borrowings$0$0$1.0M$120.0M$150.0M$179.0M$267.0M$276.0M$340.0M$351.0M
Other Liabilities$6.0M$1.0M$1.0M$8.0M$11.0M$25.0M$44.0M$43.0M$113.0M$144.0M
Equity$0$0$0$0$0$1.0M$1.0M$1.0M$0$0
Reserves−$6.0M$2.0M−$1.0M$28.0M$86.0M$115.0M$96.0M$61.0M$146.0M$329.0M

For Nutex Health Inc., operating cash flow was positive in 7 of 10 reported years; free cash flow in the latest year was $246.0M; free cash flow was positive in 5 of 10 years; financing activities used $4.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$0−$1.0M$0$12.0M$87.0M$173.0M$51.0M$1.0M$23.0M$248.0M
Investing Cash Flow$0$0$0−$64.0M−$122.0M−$74.0M−$19.0M−$21.0M−$5.0M−$8.0M
Financing Cash Flow$0$0$0$5.0M$10.0M$22.0M$4.0M$0$6.0M−$4.0M
Net Cash Flow$0$0$0$3.0M$18.0M$11.0M−$2.0M−$12.0M$22.0M$145.0M
Free Cash Flow$0−$1.0M$0−$20.0M$25.0M$137.0M$36.0M−$8.0M$21.0M$246.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.33
EV / EBITDA3.88
FCF Yield21.44%
Quick Ratio4.72
Interest Coverage16.21
Return 1Y59.61%
Return 3Y392.68%
Return 5Y—

Nutex Health Inc. (NUTX) financials — frequently asked questions

What is Nutex Health Inc.'s annual revenue?

Nutex Health Inc. (NUTX) reported annual revenue of $875.0M in its most recent fiscal year.

What is Nutex Health Inc.'s net profit?

Nutex Health Inc. (NUTX) reported net profit of $71.0M in its most recent fiscal year.

What is NUTX EV/EBITDA?

Nutex Health Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 3.88.

Revenue and earnings of other Medical - Care Facilities stocks

HCA revenue $75.6BTHC revenue $21.3BEHC revenue $5.9BDVA revenue $13.6BENSG revenue $5.1BUHS revenue $17.4BCHE revenue $2.5BLFST revenue $1.4BOPCH revenue $5.7BHIMS revenue $2.3BAll Medical - Care Facilities stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
NUTX Overview NUTX Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.